Results 51 to 60 of about 194,677 (213)
Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia
Journal of Lipid Research, 2002 Atorvastatin, a synthetic HMG-CoA reductase inhibitor used for the treatment of hyperlipidemia and the prevention of coronary artery disease, significantly lowers plasma cholesterol and low-density lipoprotein cholesterol (LDL-C) levels.
Jeffrey S. Cohn +11 more
doaj +1 more source
Hyperlipidemia and male infertility [PDF]
, 2021 Hyperlipidemia is a common disease affecting 25% of adults in developed nations. Approximately 50% of the middle-aged adult population have been reported to have total cholesterol level above the normal range. Worldwide, the incidence of dyslipidaemia is
Hamad Alfarisi, Hamad Abdulsalam +1 more
core +1 more source
New advances in the hyperlipidemia treatment
, 2021 Current therapies of cardiovascular diseases have potency in reducing the risks. However, there are limitations and residual risks that remain. Non-adherence, drug resistance and side effects much often hinder the treatments that the optimal lipid level ...
YoungRyun, Mo
core
Attenuates Hyperglycemia, Hyperlipidemia, and Oxidative Stress in Diabetic Rats
, 2020 This study investigates the effect of fatty acid and sterol rich extract from the stem back of S. roxburghii (MESS) on hyperglycemia, hyperlipidemia, and oxidative stress induced by high fat diet/streptozotocin (HFD/STZ) in rats.
Makinde, Emmanuel Ayobami +7 more
core +1 more source
Lipids in Health and Disease, 2020 Background To evaluate associations between diabetes mellitus (DM) coexisting with hyperlipidemia and mortality in peritoneal dialysis (PD) patients. Methods This was a retrospective cohort study with 2939 incident PD patients in China from January 2005 ...
Xin Wei +7 more
doaj +1 more source
Frontiers in Endocrinology, 2023 ObjectiveThe Klotho protein is a well-documented anti-aging protein known for its diverse biological functions. Hyperlipidemia is an established independent risk factor for various chronic diseases.
Shaohua Yan +4 more
doaj +1 more source
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments
, 2023 Postprandial hyperlipidemia showing postprandial increases in serum triglyceride (TG) is associated with the development of atherosclerotic cardiovascular disease (ASCVD).
Hidekatsu Yanai +3 more
core +1 more source
Frequency of Hyperlipidemia in the Diagnosed Type 2 Diabetic Patients [PDF]
, 2021 OBJECTIVES: The primary event in the development of type-2 diabetes is directly associated with lipid metabolism derangement occurring due to insulin resistance.
Rehman, Safia +11 more
core +1 more source
Overexpression of apoC-I in apoE-null mice
Journal of Lipid Research, 2002 Apolipoprotein C-I (apoC22222222246) has been proposed to act primarily via interference with apoE-mediated lipoprotein uptake. To define actions of apoC-I that are independent of apoE, we crossed a moderately overexpressing human apoC-I transgenic ...
Karin Conde-Knape +4 more
doaj +1 more source
Atorvastatin’s Therapeutic Potential in Atherosclerosis: Inhibiting TGF-β-Induced Proteoglycan Glycosaminoglycan Chain Elongation through ROS-ERK1/2-Smad2L Signaling Pathway Modulation in Vascular Smooth Muscle Cells [PDF]
Cell JournalObjective: According to the response-to-retention hypothesis, the inception of atherosclerosis is attributed to thedeposition and retention of lipoprotein in the arterial intima, facilitated by altered proteoglycans with hyperelongatedglycosaminoglycan ...
Hossein Ghaderi-Zefrehi +4 more
doaj +1 more source